These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9554178)

  • 1. Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci.
    Bostic GD; Perri MB; Thal LA; Zervos MJ
    Diagn Microbiol Infect Dis; 1998 Feb; 30(2):109-12. PubMed ID: 9554178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ; Cappelletty DM; Moldovan T; Aeschlimann JR; Kaatz GW
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.
    Perri MB; Chow JW; Zervos MJ
    Diagn Microbiol Infect Dis; 1993; 17(2):151-5. PubMed ID: 8243036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients.
    Wiland AM; Plaisance KI; Schwalbe RS
    Pharmacotherapy; 1994; 14(1):89-94. PubMed ID: 8159604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.
    Traub WH; Leonhard B
    Chemotherapy; 1993; 39(2):82-7. PubMed ID: 8458250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.
    Giamarellos-Bourboulis EJ; Sambatakou H; Grecka P; Giamarellou H
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):657-61. PubMed ID: 9832270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.
    Sahm DF; Boonlayangoor S; Schulz JE
    J Clin Microbiol; 1991 Nov; 29(11):2595-8. PubMed ID: 1774267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility patterns of enterococci causing infections.
    Oncu S; Punar M; Eraksoy H
    Tohoku J Exp Med; 2004 Jan; 202(1):23-9. PubMed ID: 14738321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal action of gentamicin against enterococci that are sensitive, or exhibit low- or high-level resistance to gentamicin.
    Fasola EL; Moody JA; Shanholtzer CJ; Peterson LR
    Diagn Microbiol Infect Dis; 1994 May; 19(1):57-60. PubMed ID: 7956015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.